Mark’s PET Imaging Story

In March 2011, I was diagnosed with prostate cancer with a Gleason score of 7 (out of 10). As it is for anyone who is told they have cancer, I was shocked, but I accepted it and discussed the options with my doctor’s recommendations.

Because of the severity of my cancer, my physician recommended me for radical prostatectomy, and I underwent surgery in May that year.  

All was well for a while, but in 2021 during a routine exam, my Prostate-Specific Antigen (PSA) levels indicated a strong likelihood that the prostate cancer had returned. My doctors recommended a PET/CT scan to get a clearer idea of what was going on.  

My scan showed hot spots around my prostate bed and unexpectedly in my colon. My doctors recommended a colonoscopy which confirmed that I also had colorectal cancer. This presented a challenge for my medical team as they had to treat two separate cancers at the same time. However, the good news is my doctors were able to quickly start me on treatment, thanks to the information from this PET/CT scan. 


Today, the tumor in my colon is gone, and my prostate cancer is in remission.  

My doctor’s fast-acting diagnosis is why I can tell my story today- and that happened when it did, thanks to my PET/CT scan. However, access to many of the innovative diagnostic radiopharmaceuticals needed for these scans is severely limited for Medicare beneficiaries due to flawed payment policy. Unless this issue is addressed, scans that can diagnose and monitor conditions such as Parkinson’s Disease, advanced cardiac disorders, and prostate, breast, and brain cancers will be severely limited.

Join me and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose cancers like mine.

More Articles

National Colorectal Cancer Awareness Month: The Importance of Early Detection

March 13, 2025

Every March, we recognize National Colorectal Cancer Awareness Month as an opportunity to raise awareness about this all-too-common…

Read More

Lung Cancer Awareness Month: Why AI-Enabled Imaging Tools Matter

November 15, 2024

This year, an estimated 234,580 Americans will be diagnosed with lung cancer. This Lung Cancer Awareness Month, we…

Read More

Breast Cancer Awareness Month: AI’s Role in Improving Early Detection  

October 15, 2024

This October, Right Scan Right Time recognizes National Breast Cancer Awareness Month, a time to raise awareness about…

Read More

Patient Fly-In Highlights Value of Focused Ultrasound Technologies

August 27, 2024

On July 11, AdvaMed Imaging’s Focused Ultrasound Section and the Focused Ultrasound Foundation (FUS) hosted their fifth annual…

Read More